Cero Therapeutics Files 8-K on Officer/Director Changes & Shareholder Votes
Ticker: CEROW · Form: 8-K · Filed: May 29, 2025 · CIK: 1870404
Sentiment: neutral
Topics: governance, officer-changes, director-changes, shareholder-vote
TL;DR
Cero Therapeutics 8-K: Leadership changes, officer appointments, and shareholder votes filed May 29, 2025.
AI Summary
Cero Therapeutics Holdings, Inc. filed an 8-K on May 29, 2025, reporting on several key events. These include the departure of directors or certain officers, the election of directors, the appointment of certain officers, and updates to compensatory arrangements for officers. The filing also covers the submission of matters to a vote of security holders and includes financial statements and exhibits.
Why It Matters
This filing provides crucial updates on the company's leadership and governance, which can impact strategic direction and investor confidence.
Risk Assessment
Risk Level: medium — Changes in directors and officers, along with shareholder votes, can indicate internal shifts or strategic realignments that may carry inherent risks.
Key Players & Entities
- CERO THERAPEUTICS HOLDINGS, INC. (company) — Registrant
- May 29, 2025 (date) — Earliest event reported
- PHOENIX BIOTECH ACQUISITION CORP. (company) — Former company name
FAQ
What specific officer or director positions were affected by the changes reported in the 8-K?
The filing indicates "Departure of Directors or Certain Officers" and "Appointment of Certain Officers" but does not specify the names or exact positions in the provided text.
Were there any new compensatory arrangements for officers detailed in this filing?
Yes, the filing explicitly mentions "Compensatory Arrangements of Certain Officers" as an item of information being reported.
What matters were submitted to a vote of security holders?
The filing states "Submission of Matters to a Vote of Security Holders" but does not detail the specific matters in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on May 29, 2025.
What was Cero Therapeutics Holdings, Inc. formerly known as?
Cero Therapeutics Holdings, Inc. was formerly known as PHOENIX BIOTECH ACQUISITION CORP.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 29, 2025 regarding CERO THERAPEUTICS HOLDINGS, INC. (CEROW).